Effect of GM1 on the Alterations Induced by Selective Neurotoxins in the Developing CNS

[1]  Z. Rossetti,et al.  Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP , 1986, Neuropharmacology.

[2]  A. Gorio,et al.  In vivo treatment with GM1 prevents the rapid decay of ATPase activities and mitochondrial damage in hippocampal slices , 1986, Brain Research.

[3]  A. Gorio.  Ganglioside enhancement of neuronal differentiation, plasticity, and repair. , 1986, CRC critical reviews in clinical neurobiology.

[4]  A. Gorio,et al.  GM1 ganglioside counteracts selective neurotoxin‐induced lesion of developing serotonin neurons in rat spinal cord , 1986, Journal of neuroscience research.

[5]  F. Walsh,et al.  Ganglioside GM1 Does Not Initiate, but Enhances Neurite Regeneration of Nerve Growth Factor‐Dependent Sensory Neurones , 1985, Journal of neurochemistry.

[6]  A. Gorio,et al.  GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine , 1984, Neuroscience.

[7]  A. Gorio,et al.  Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain. , 1984, Brain research.

[8]  A. Gorio,et al.  Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins , 1984, Journal of neuroscience research.

[9]  R. Ledeen.  Biology of gangliosides: Neuritogenic and neuronotrophic properties , 1984, Journal of neuroscience research.

[10]  M. Raiteri,et al.  The functional recovery of damaged brain: The effect of GM1 monosialoganglioside , 1984, Journal of neuroscience research.

[11]  M. Skup,et al.  Effect of GM1 ganglioside treatment on postlesion responses of cholinergic enzymes in rat hippocampus after various partial deafferentations , 1984, Journal of neuroscience research.

[12]  S. Karpiak.  Exogenous gangliosides enhance recovery from cns injury. , 1984, Advances in experimental medicine and biology.

[13]  A. Gorio,et al.  Gangliosides' dual mode of action: A Working hypothesis , 1984, Journal of neuroscience research.

[14]  M. Schwartz,et al.  Antibodies to gangliosides inhibit goldfish optic nerve regeneration in vivo , 1984, Journal of neuroscience research.

[15]  P. Spoerri.  Effects of gangliosides on the in vitro development of neuroblastoma cells: An ultrastructural study , 1983, International Journal of Developmental Neuroscience.

[16]  S. Ando.  Gangliosides in the nervous system , 1983, Neurochemistry International.

[17]  K. Fuxe,et al.  Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. , 1983, Acta physiologica Scandinavica.

[18]  S. Karpiak.  Ganglioside treatment improves recovery of alternation behavior after unilateral entorhinal cortex lesion , 1983, Experimental Neurology.

[19]  S. Mahadik,et al.  Gangliosides accelerate rat neonatal learning and levels of cortical acetylcholinesterases. , 1983, Developmental neuroscience.

[20]  A. Gorio,et al.  Gangliosides enhance neurite outgrowth in PC12 cells. , 1983, Brain research.

[21]  P. Marini,et al.  Muscle reinnervation—III. Motoneuron sprouting capacity, enhancement by exogenous gangliosides , 1983, Neuroscience.

[22]  L. Agnati,et al.  GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system , 1983, Brain Research.

[23]  U. Otten,et al.  Nerve growth factor antagonizes the neurotoxic action of capsaicin on primary sensory neurones , 1983, Nature.

[24]  P. Monroe,et al.  Characterization of Multiple [3H]5–Hydroxytryptamine Binding Sites in Rat Spinal Cord Tissue , 1983, Journal of neurochemistry.

[25]  R. Shoup,et al.  Simultaneous multiple electrode liquid chromatographic-electrochemical assay for catecholamines, indole-amines and metabolites in brain tissue. , 1983, Journal of chromatography.

[26]  M. Schwartz,et al.  Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Schwartz,et al.  Antiganglioside Antibodies Inhibit Neuritic Outgrowth from Regenerating Goldfish Retinal Explants , 1982, Journal of neurochemistry.

[28]  G. Jonsson,et al.  Modulation of 6-hydroxydopamine induced alteration of the postnatal development of central noradrenaline neurons , 1982, Brain Research Bulletin.

[29]  C. Sachs,et al.  Changes in the development of central noradrenaline neurons after neonatal axon lesions , 1982, Brain Research Bulletin.

[30]  G. Jonsson,et al.  Response of central monoamine neurons following an early neurotoxic lesion. , 1982, Bibliotheca anatomica.

[31]  L. Facci,et al.  Morphological and biochemical effects of gangliosides in neuroblastoma cells. , 1982, Developmental neuroscience.

[32]  G. Schneider.  Early lesions and abnormal neuronal connections , 1981, Trends in Neurosciences.

[33]  C. Milstein,et al.  Immunocytochemical detection of serotonin with monoclonal antibodies. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[34]  R. Nagele,et al.  Ganglioside stimulation of axonal sprouting in vitro. , 1981, Science.

[35]  M. Rapport,et al.  Abnormal maturation of cerebral cortex and behavioral deficit in adult rats after neonatal administration of antibodies to ganglioside. , 1981, Brain research.

[36]  G. Carmignoto,et al.  Motor nerve sprouting induced by ganglioside treatment. Possible implications for gangliosides on neuronal growth , 1980, Brain Research.

[37]  S. Vincent,et al.  Neurotoxic action of capsaicin on spinal substance P neurons , 1980, Brain Research.

[38]  F. Lembeck,et al.  DECREASE OF SUBSTANCE P IN PRIMARY AFFERENT NEURONES AND IMPAIRMENT OF NEUROGENIC PLASMA EXTRAVASATION BY CAPSAICIN , 1980, British journal of pharmacology.

[39]  L. Svennerholm.  Gangliosides and synaptic transmission. , 1980, Advances in experimental medicine and biology.

[40]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[41]  C. Milstein,et al.  Detection of substance P in the central nervous system by a monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Kissinger,et al.  DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY , 1978, Journal of neurochemistry.

[43]  A. Jancsó-Gábor,et al.  Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones , 1977, Nature.

[44]  A. Oke,et al.  Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. , 1976, Life sciences.

[45]  F. Aporti,et al.  Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation. , 1976, Advances in experimental medicine and biology.

[46]  Coons Ah.  Fluorescent antibody methods , 1968 .